• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Vaxess Technologies

Vaxess raises $9M to support drug delivery patch, GLP-1 work

April 9, 2025 By Sean Whooley

Vaxess Technologies MIMIX vaccine patch

Shelf-stable vaccine patch maker Vaxess Technologies announced today that it received an additional $9 million in funding. Participants in the latest funding round for Woburn, Massachusetts-based Vaxess included RA Capital Management and Engine Ventures. The company plans to use the funds to continue to advance its work in GLP-1 therapeutics and to expand manufacturing capabilities. It […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Funding Roundup, Pharmaceuticals Tagged With: Vaxess Technologies

Vaccine patch maker Vaxess raises $12M, names new CEO

May 22, 2024 By Sean Whooley

Vaxess Technologies MIMIX vaccine patch

Shelf-stable vaccine patch maker Vaxess Technologies announced today that it raised $12 million and appointed Rachel Sha as its new CEO. This round brings the company’s total funding to more than $90 million after it raised $9 million last September as well. Investors included RA Capital Management, Engine Ventures, GHIC and Mission Bio Capital. Cambridge, […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Personnel, Pharmaceuticals Tagged With: Vaxess Technologies

Vaxess raises $9M to support shelf-stable vaccine patch

September 13, 2023 By Sean Whooley

Vaxess Technologies MIMIX vaccine patch

Vaxess Technologies announced today that it raised an additional $9 million in venture capital funding to support its vaccine delivery technology. Cambridge, Massachusetts-based Vaxess develops a shelf-stable vaccine patch with the potential for self-application. The company’s MiMix system features sustained-release technology for administering vaccines and therapeutics. For vaccines, its controlled release simulates the pace of […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals, Technology Tagged With: Vaxess Technologies

Vaccine patch maker Vaxess names former Sanofi exec as chief strategy officer

March 22, 2023 By Sean Whooley

Vaxess Technologies MIMIX vaccine patch

Vaxess Technologies, developer of a shelf-stable vaccine patch, announced today that it named Steve Bende as its new chief strategy officer. Bende previously served as global head of new products at Sanofi Pasteur. He led international, multifunctional teams at the pharmaceutical giant. That included assessing the commercial viability of potential new products. Prior to Sanofi, […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Personnel, Pharmaceuticals Tagged With: Personnel Moves, Vaxess Technologies

Interim data supports Vaxess shelf-stable flu vaccine patch

December 14, 2022 By Sean Whooley

Vaxess Technologies MIMIX vaccine patch

Vaxess Technologies today announced positive interim results from a first-in-human trial of its influenza vaccine patch. Cambridge, Massachusetts-based Vaxess evaluated VX-103, a monovalent seasonal influenza vaccine patch. The trial included 45 healthy patients and evaluated the H1N1 influenza antigen from Vaxess’ partner, GC Biopharma. Delivery of the vaccine took place through the Vaxess Mimix patch. […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Vaxess Technologies

Vaxess Technologies raises $2M for its silk-based vaccine delivery through the skin

March 26, 2021 By Sean Whooley

Vaxess Technologies today filed an SEC Form D to confirm the sale of $2 million in debt, options, warrants or other rights to buy securities. According to the filing, three investors contributed to the new notice offering, which made its first sale on Monday, March 22, 2021, before reaching its total offering amount of $2 […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals Tagged With: Vaxess Technologies

Vaxess Technologies lands $6m for microneedle vaccines

March 6, 2017 By Sarah Faulkner

Vaxess Technologies said today that it won 2 grants from the Bill & Melinda Gates Foundation totalling up to $6 million for the development of inactivated polio and live attenuated measles rubella vaccines using the company’s Mimix sustained-release microneedle patch technology. The company’s Mimix technology is designed for sustained, transdermal delivery of vaccines and inmmunotherapies, […]

Filed Under: Drug-Device Combinations, Featured, Research & Development, Wall Street Beat Tagged With: Vaxess Technologies

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS